AVEO Oncology
AVEO
#7231
Rank
A$0.73 B
Marketcap
A$21.04
Share price
0.00%
Change (1 day)
146.89%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -A$40.76 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are A$94.31 Million. In 2021 the company made an earning of -A$74.82 Million a decrease over its 2020 earnings that were of -A$49.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$40.76 Million-45.52%
2021 -A$74.82 Million49.9%
2020 -A$49.92 Million-479.04%
2019 A$13.16 M-276.17%
2018 -A$7.48 Million-91.79%
2017 -A$91.07 Million142.38%
2016 -A$37.58 Million78.51%
2015 -A$21.05 Million-71.55%
2014 -A$73.98 Million-50.72%
2013 -A$0.16 Billion-4.88%
2012 -A$0.16 Billion-426.29%
2011 A$48.36 M-159.85%
2010 -A$80.83 Million35.33%
2009 -A$59.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$43.65 B-107,283.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.74 B-31,392.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.27 B-5,689.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.23 B-17,858.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.46 B-33,148.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.17 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA